These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 36788362)

  • 1. Giant cell arteritis: reviewing the advancing diagnostics and management.
    Bilton EJ; Mollan SP
    Eye (Lond); 2023 Aug; 37(12):2365-2373. PubMed ID: 36788362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advances in giant cell arteritis.
    Kaushik M; Ponte C; Mollan SP
    Curr Opin Neurol; 2021 Feb; 34(1):133-141. PubMed ID: 33230039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the clinical approach to giant cell arteritis.
    Piccus R; Hansen MS; Hamann S; Mollan SP
    Clin Med (Lond); 2022 Mar; 22(2):107-111. PubMed ID: 35304369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Headache Federation recommendations for neurologists managing giant cell arteritis.
    Mollan SP; Paemeleire K; Versijpt J; Luqmani R; Sinclair AJ
    J Headache Pain; 2020 Mar; 21(1):28. PubMed ID: 32183689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell arteritis and innovative treatments.
    Costanzo G; Ledda AG; Sambugaro G
    Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):327-333. PubMed ID: 37357797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual loss in giant cell arteritis 3 weeks after steroid initiation.
    Le Goueff A; Peters J; Willcocks L; Jayne D
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30846454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell arteritis.
    Pepper K
    Postgrad Med; 2023 Jan; 135(sup1):22-32. PubMed ID: 37021621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era for giant cell arteritis.
    Lyons HS; Quick V; Sinclair AJ; Nagaraju S; Mollan SP
    Eye (Lond); 2020 Jun; 34(6):1013-1026. PubMed ID: 31582795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delays in recognition and management of giant cell arteritis: results from a retrospective audit.
    Ezeonyeji AN; Borg FA; Dasgupta B
    Clin Rheumatol; 2011 Feb; 30(2):259-62. PubMed ID: 21086005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-vessel giant cell arteritis: diagnosis, monitoring and management.
    Koster MJ; Matteson EL; Warrington KJ
    Rheumatology (Oxford); 2018 Feb; 57(suppl_2):ii32-ii42. PubMed ID: 29982778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis.
    Man-Ger Sun M; Pope JE
    Best Pract Res Clin Rheumatol; 2022 Dec; 36(4):101822. PubMed ID: 36907732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.
    El Chami S; Springer JM
    Rheum Dis Clin North Am; 2022 May; 48(2):493-506. PubMed ID: 35400374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.
    Hayreh SS; Zimmerman B; Kardon RH
    Acta Ophthalmol Scand; 2002 Aug; 80(4):355-67. PubMed ID: 12190776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant cell arteritis: diagnosing and treating inflammatory disease in older adults.
    Azhar SS; Tang RA; Dorotheo EU
    Geriatrics; 2005 Aug; 60(8):26-30. PubMed ID: 16092890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cell arteritis: epidemiology, diagnosis, and management.
    Gonzalez-Gay MA; Martinez-Dubois C; Agudo M; Pompei O; Blanco R; Llorca J
    Curr Rheumatol Rep; 2010 Dec; 12(6):436-42. PubMed ID: 20857242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J; Warrington KJ
    Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in giant cell arteritis.
    Frohman L; Wong AB; Matheos K; Leon-Alvarado LG; Danesh-Meyer HV
    Surv Ophthalmol; 2016; 61(4):400-21. PubMed ID: 26774550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Giant Cell Arteritis.
    Guevara M; Kollipara CS
    Curr Rheumatol Rep; 2018 Apr; 20(5):25. PubMed ID: 29611005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.